Nutriband Inc (NTRB)

$5.93

-0.26

(-4.2%)

Market is closed - opens 7 PM, 04 Nov 2024

Performance

  • $5.93
    $6.34
    $5.93
    downward going graph

    0.0%

    Downside

    Day's Volatility :6.47%

    Upside

    6.47%

    downward going graph
  • $1.93
    $9.60
    $5.93
    downward going graph

    67.5%

    Downside

    52 Weeks Volatility :79.92%

    Upside

    38.2%

    downward going graph

Returns

PeriodNutriband IncIndex (Russel 2000)
3 Months
4.4%
0.0%
6 Months
62.47%
0.0%
1 Year
165.92%
0.0%
3 Years
1.89%
-25.1%

Highlights

Market Capitalization
68.7M
Book Value
$0.73
Earnings Per Share (EPS)
-0.81
Wall Street Target Price
18.0
Profit Margin
0.0%
Operating Margin TTM
-462.5%
Return On Assets TTM
-30.13%
Return On Equity TTM
-60.41%
Revenue TTM
2.0M
Revenue Per Share TTM
0.24
Quarterly Revenue Growth YOY
-14.299999999999999%
Gross Profit TTM
750.4K
EBITDA
-5.5M
Diluted Eps TTM
-0.81
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Nutriband Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 203.54%

Current $5.93
Target $18.00

Technicals Summary

Sell

Neutral

Buy

Nutriband Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nutriband Inc
Nutriband Inc
-0.67%
62.47%
165.92%
1.89%
3.41%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-18.91%
-10.03%
3.03%
32.07%
171.22%
Biontech Se
Biontech Se
-6.32%
20.86%
20.53%
-61.49%
487.66%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
0.87%
82.23%
69.57%
63.38%
198.57%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
1.94%
17.73%
25.11%
159.71%
136.25%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nutriband Inc
Nutriband Inc
NA
NA
NA
0.0
-0.6
-0.3
NA
0.73
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
20.75
20.75
1.18
44.77
0.17
0.08
NA
242.47
Biontech Se
Biontech Se
160.8
NA
0.04
-2.76
-0.03
-0.02
NA
80.22
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-2.39
-15.01
0.02
NA
-0.02
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.84
NA
1.21
0.16
-0.03
0.13
NA
57.26
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nutriband Inc
Nutriband Inc
Buy
$68.7M
3.41%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$101.7B
171.22%
20.75
32.04%
Biontech Se
Biontech Se
Buy
$27.1B
487.66%
160.8
-18.75%
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
Buy
$36.5B
198.57%
NA
-3.11%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$122.9B
136.25%
32.84
-4.74%

Insights on Nutriband Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 408.53K → 442.83K (in $), with an average increase of 7.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -1.89M → -1.70M (in $), with an average increase of 11.3% per quarter

  • Vs VRTX

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 63.4% return, outperforming this stock by 61.5%

Institutional Holdings

  • Vanguard Group Inc

    0.99%
  • Geode Capital Management, LLC

    0.63%
  • Millennium Management LLC

    0.19%
  • State Street Corp

    0.16%
  • Atria Wealth Solutions, Inc.

    0.10%
  • Morgan Stanley - Brokerage Accounts

    0.06%

Company Information

nutriband inc. is a health and pharmaceutical company based in, oviedo, florida. nutriband's primary focus is on transdermal and topical technologies for product development.

Organization
Nutriband Inc
Employees
0
CEO
Mr. Serguei Melnik
Industry
Health Technology

FAQs